Tumor-associated macrophages (TAM) are key effectors in cancer-related inflammation and reportedly, activated macrophages secrete IL-1β resulting in the activation of NF-κB signaling favoring tumorigenic progression (164, 165). Here, NFKB1 is linked to neoplasm.